Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus

Joan M. Von Feldt, Lisabeth Scalzi, Andrew J. Cucchiara, Suneetha Morthala, Carmel Kealey, Stephanie D. Flagg, Anna Genin, Alison L. Van Dyke, Eleni Nackos, Avantika Chander, Erika Gehrie, Randy Q. Cron, Alexander S. Whitehead

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Objective. To compare the incidence and extent of coronary artery calcification (CAC) as measured by electron beam computed tomography (EBCT) in patients with systemic lupus erythematosus (SLE) and controls, and to identify variables associated with CAC in patients with SLE. Methods. Female patients with SLE and matched controls were recruited; EBCT of the coronary arteries was performed, and laboratory values (including the homocysteine concentration, the lipid level, the high-sensitivity C-reactive protein [hsCRP] concentration, the glomerular filtration rate [GFR], and the level of soluble CD154 [sCD154]) were determined. For patients, the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index and the SLE Disease Activity Index scores were recorded. Tests of association between the CAC score and the above-mentioned variables were performed. Results. The incidence of CAC was higher in patients with SLE than in controls (P = 0.009), and patients had a higher mean raw CAC (rCAC) score (87.9 versus 9.6 in controls; P = 0.02). In particular, more CAC-positive patients than CAC-positive controls had rCAC scores above the 75th percentile (P = 0.003). Among both patients and controls, those with CAC were ∼10 years older than those without CAC. In addition to age, a significant determinant of positive CAC status in both groups was the number of cardiovascular risk factors. In patients with SLE, CAC was associated with a higher homocysteine concentration, a lower GFR, and longer disease duration. In controls, the total cholesterol level correlated positively with CAC. When multivariate logistic regression methods were applied to candidate explanatory variables, homocysteine concentration, age, and disease duration (but not the levels of sCD154 or hsCRP) contributed significantly to CAC status. The methylenetetrahydrofolate reductase C677T genotype was not a predictor of hyperhomocysteinemia or CAC status. Conclusion. Among patients with SLE, the homocysteine concentration, the GFR, age, and disease duration were associated with CAC. CAC occurred more frequently and was more extensive in patients with SLE than in controls, suggesting that EBCT could be used to detect premature atherosclerosis in the former group. An elevated homocysteine concentration might identify patients with SLE who are likely to have premature atherosclerosis and who would benefit from evaluation of CAC by EBCT.

Original languageEnglish (US)
Pages (from-to)2220-2227
Number of pages8
JournalArthritis and rheumatism
Volume54
Issue number7
DOIs
StatePublished - Jul 1 2006

Fingerprint

Homocysteine
Systemic Lupus Erythematosus
Coronary Vessels
X Ray Computed Tomography
Glomerular Filtration Rate
C-Reactive Protein
Atherosclerosis
Methylenetetrahydrofolate Reductase (NADPH2)
Hyperhomocysteinemia
Incidence

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Pharmacology (medical)

Cite this

Von Feldt, Joan M. ; Scalzi, Lisabeth ; Cucchiara, Andrew J. ; Morthala, Suneetha ; Kealey, Carmel ; Flagg, Stephanie D. ; Genin, Anna ; Van Dyke, Alison L. ; Nackos, Eleni ; Chander, Avantika ; Gehrie, Erika ; Cron, Randy Q. ; Whitehead, Alexander S. / Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. In: Arthritis and rheumatism. 2006 ; Vol. 54, No. 7. pp. 2220-2227.
@article{a92adf61728240aa85c856606316f266,
title = "Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus",
abstract = "Objective. To compare the incidence and extent of coronary artery calcification (CAC) as measured by electron beam computed tomography (EBCT) in patients with systemic lupus erythematosus (SLE) and controls, and to identify variables associated with CAC in patients with SLE. Methods. Female patients with SLE and matched controls were recruited; EBCT of the coronary arteries was performed, and laboratory values (including the homocysteine concentration, the lipid level, the high-sensitivity C-reactive protein [hsCRP] concentration, the glomerular filtration rate [GFR], and the level of soluble CD154 [sCD154]) were determined. For patients, the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index and the SLE Disease Activity Index scores were recorded. Tests of association between the CAC score and the above-mentioned variables were performed. Results. The incidence of CAC was higher in patients with SLE than in controls (P = 0.009), and patients had a higher mean raw CAC (rCAC) score (87.9 versus 9.6 in controls; P = 0.02). In particular, more CAC-positive patients than CAC-positive controls had rCAC scores above the 75th percentile (P = 0.003). Among both patients and controls, those with CAC were ∼10 years older than those without CAC. In addition to age, a significant determinant of positive CAC status in both groups was the number of cardiovascular risk factors. In patients with SLE, CAC was associated with a higher homocysteine concentration, a lower GFR, and longer disease duration. In controls, the total cholesterol level correlated positively with CAC. When multivariate logistic regression methods were applied to candidate explanatory variables, homocysteine concentration, age, and disease duration (but not the levels of sCD154 or hsCRP) contributed significantly to CAC status. The methylenetetrahydrofolate reductase C677T genotype was not a predictor of hyperhomocysteinemia or CAC status. Conclusion. Among patients with SLE, the homocysteine concentration, the GFR, age, and disease duration were associated with CAC. CAC occurred more frequently and was more extensive in patients with SLE than in controls, suggesting that EBCT could be used to detect premature atherosclerosis in the former group. An elevated homocysteine concentration might identify patients with SLE who are likely to have premature atherosclerosis and who would benefit from evaluation of CAC by EBCT.",
author = "{Von Feldt}, {Joan M.} and Lisabeth Scalzi and Cucchiara, {Andrew J.} and Suneetha Morthala and Carmel Kealey and Flagg, {Stephanie D.} and Anna Genin and {Van Dyke}, {Alison L.} and Eleni Nackos and Avantika Chander and Erika Gehrie and Cron, {Randy Q.} and Whitehead, {Alexander S.}",
year = "2006",
month = "7",
day = "1",
doi = "10.1002/art.21967",
language = "English (US)",
volume = "54",
pages = "2220--2227",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

Von Feldt, JM, Scalzi, L, Cucchiara, AJ, Morthala, S, Kealey, C, Flagg, SD, Genin, A, Van Dyke, AL, Nackos, E, Chander, A, Gehrie, E, Cron, RQ & Whitehead, AS 2006, 'Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus', Arthritis and rheumatism, vol. 54, no. 7, pp. 2220-2227. https://doi.org/10.1002/art.21967

Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. / Von Feldt, Joan M.; Scalzi, Lisabeth; Cucchiara, Andrew J.; Morthala, Suneetha; Kealey, Carmel; Flagg, Stephanie D.; Genin, Anna; Van Dyke, Alison L.; Nackos, Eleni; Chander, Avantika; Gehrie, Erika; Cron, Randy Q.; Whitehead, Alexander S.

In: Arthritis and rheumatism, Vol. 54, No. 7, 01.07.2006, p. 2220-2227.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus

AU - Von Feldt, Joan M.

AU - Scalzi, Lisabeth

AU - Cucchiara, Andrew J.

AU - Morthala, Suneetha

AU - Kealey, Carmel

AU - Flagg, Stephanie D.

AU - Genin, Anna

AU - Van Dyke, Alison L.

AU - Nackos, Eleni

AU - Chander, Avantika

AU - Gehrie, Erika

AU - Cron, Randy Q.

AU - Whitehead, Alexander S.

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Objective. To compare the incidence and extent of coronary artery calcification (CAC) as measured by electron beam computed tomography (EBCT) in patients with systemic lupus erythematosus (SLE) and controls, and to identify variables associated with CAC in patients with SLE. Methods. Female patients with SLE and matched controls were recruited; EBCT of the coronary arteries was performed, and laboratory values (including the homocysteine concentration, the lipid level, the high-sensitivity C-reactive protein [hsCRP] concentration, the glomerular filtration rate [GFR], and the level of soluble CD154 [sCD154]) were determined. For patients, the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index and the SLE Disease Activity Index scores were recorded. Tests of association between the CAC score and the above-mentioned variables were performed. Results. The incidence of CAC was higher in patients with SLE than in controls (P = 0.009), and patients had a higher mean raw CAC (rCAC) score (87.9 versus 9.6 in controls; P = 0.02). In particular, more CAC-positive patients than CAC-positive controls had rCAC scores above the 75th percentile (P = 0.003). Among both patients and controls, those with CAC were ∼10 years older than those without CAC. In addition to age, a significant determinant of positive CAC status in both groups was the number of cardiovascular risk factors. In patients with SLE, CAC was associated with a higher homocysteine concentration, a lower GFR, and longer disease duration. In controls, the total cholesterol level correlated positively with CAC. When multivariate logistic regression methods were applied to candidate explanatory variables, homocysteine concentration, age, and disease duration (but not the levels of sCD154 or hsCRP) contributed significantly to CAC status. The methylenetetrahydrofolate reductase C677T genotype was not a predictor of hyperhomocysteinemia or CAC status. Conclusion. Among patients with SLE, the homocysteine concentration, the GFR, age, and disease duration were associated with CAC. CAC occurred more frequently and was more extensive in patients with SLE than in controls, suggesting that EBCT could be used to detect premature atherosclerosis in the former group. An elevated homocysteine concentration might identify patients with SLE who are likely to have premature atherosclerosis and who would benefit from evaluation of CAC by EBCT.

AB - Objective. To compare the incidence and extent of coronary artery calcification (CAC) as measured by electron beam computed tomography (EBCT) in patients with systemic lupus erythematosus (SLE) and controls, and to identify variables associated with CAC in patients with SLE. Methods. Female patients with SLE and matched controls were recruited; EBCT of the coronary arteries was performed, and laboratory values (including the homocysteine concentration, the lipid level, the high-sensitivity C-reactive protein [hsCRP] concentration, the glomerular filtration rate [GFR], and the level of soluble CD154 [sCD154]) were determined. For patients, the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index and the SLE Disease Activity Index scores were recorded. Tests of association between the CAC score and the above-mentioned variables were performed. Results. The incidence of CAC was higher in patients with SLE than in controls (P = 0.009), and patients had a higher mean raw CAC (rCAC) score (87.9 versus 9.6 in controls; P = 0.02). In particular, more CAC-positive patients than CAC-positive controls had rCAC scores above the 75th percentile (P = 0.003). Among both patients and controls, those with CAC were ∼10 years older than those without CAC. In addition to age, a significant determinant of positive CAC status in both groups was the number of cardiovascular risk factors. In patients with SLE, CAC was associated with a higher homocysteine concentration, a lower GFR, and longer disease duration. In controls, the total cholesterol level correlated positively with CAC. When multivariate logistic regression methods were applied to candidate explanatory variables, homocysteine concentration, age, and disease duration (but not the levels of sCD154 or hsCRP) contributed significantly to CAC status. The methylenetetrahydrofolate reductase C677T genotype was not a predictor of hyperhomocysteinemia or CAC status. Conclusion. Among patients with SLE, the homocysteine concentration, the GFR, age, and disease duration were associated with CAC. CAC occurred more frequently and was more extensive in patients with SLE than in controls, suggesting that EBCT could be used to detect premature atherosclerosis in the former group. An elevated homocysteine concentration might identify patients with SLE who are likely to have premature atherosclerosis and who would benefit from evaluation of CAC by EBCT.

UR - http://www.scopus.com/inward/record.url?scp=33745899637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745899637&partnerID=8YFLogxK

U2 - 10.1002/art.21967

DO - 10.1002/art.21967

M3 - Article

C2 - 16802358

AN - SCOPUS:33745899637

VL - 54

SP - 2220

EP - 2227

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 7

ER -